1. Young LS, Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer
2004, 4:757-768.
2. Laing KG, Elia A, Jeffrey I, Matys V, Tilleray VJ, Souberbielle B, Clemens MJ: In
vivo effects of the Epstein-Barr virus small RNA EBER-1 on protein
synthesis and cell growth regulation. Virology 2002, 297:253-269.
3. Laing KG, Matys V, Clemens JM: Effects of expression of the Epstein-Barr
virus small RNA EBER-1 in heterologous cells on protein synthesis and
cell growth. Biochem Soc Trans 1995, 23:311S.
4. Ruf IK, Rhyne PW, Yang C, Cleveland JL, Sample JT: Epstein-Barr virus small
RNAs potentiate tumorigenicity of Burkitt lymphoma cells
independently of an effect on apoptosis. J Virol 2000, 74:10223-10228.
5. Zeuthen J: Epstein-Barr virus (EBV), lymphocytes and transformation. J
Cancer Res Clin Oncol 1983, 106:1-11.
6. Clarke PA, Schwemmle M, Schickinger J, Hilse K, Clemens MJ: Binding of
Epstein-Barr virus small RNA EBER-1 to the double-stranded RNAactivated
protein kinase DAI. Nucleic Acids Res 1991, 19:243-248.
7. Nanbo A, Inoue K, Adachi-Takasawa K, Takada K: Epstein-Barr virus RNA
confers resistance to interferon-alpha-induced apoptosis in Burkitt’s
lymphoma. EMBO J 2002, 21:954-965.
8. Samanta M, Iwakiri D, Kanda T, Imaizumi T, Takada K: EB virus-encoded
RNAs are recognized by RIG-I and activate signaling to induce type I
IFN. EMBO J 2006, 25:4207-4214.
9. Lerner MR, Andrews NC, Miller G, Steitz JA: Two small RNAs encoded by
Epstein-Barr virus and complexed with protein are precipitated by
antibodies from patients with systemic lupus erythematosus. Proc Natl
Acad Sci USA 1981, 78:805-809.
10. Fok V, Mitton-Fry RM, Grech A, Steitz JA: Multiple domains of EBER 1, an
Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22.
RNA 2006, 12:872-882.
11. Toczyski DP, Matera AG, Ward DC, Steitz JA: The Epstein-Barr virus (EBV)
small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBVinfected
human B lymphocytes. Proc Natl Acad Sci USA 1994,
91:3463-3467.
12. Houmani JL, Davis CI, Ruf IK: Growth-promoting properties of Epstein-Barr
virus EBER-1 RNA correlate with ribosomal protein L22 binding. J Virol
2009, 83:9844-9853.
13. Kitagawa N, Goto M, Kurozumi K, Maruo S, Fukayama M, Naoe T,
Yasukawa M, Hino K, Suzuki T, Todo S, Takada K: Epstein-Barr virusencoded
poly(A)(-) RNA supports Burkitt’s lymphoma growth through
interleukin-10 induction. EMBO J 2000, 19:6742-6750.
14. Yang L, Aozasa K, Oshimi K, Takada K: Epstein-Barr virus (EBV)-encoded
RNA promotes growth of EBV-infected T cells through interleukin-9
induction. Cancer Res 2004, 64:5332-5337.
15. Iwakiri D, Eizuru Y, Tokunaga M, Takada K: Autocrine growth of Epstein-
Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr
virus-encoded small RNA. Cancer Res 2003, 63:7062-7067.
16. Iwakiri D, Sheen TS, Chen JY, Huang DP, Takada K: Epstein-Barr virusencoded
small RNA induces insulin-like growth factor 1 and supports
growth of nasopharyngeal carcinoma-derived cell lines. Oncogene 2005,
24:1767-1773.
17. Wong HL, Wang X, Chang RC, Jin DY, Feng H, Wang Q, Lo KW, Huang DP,
Yuen PW, Takada K, Wong YC, Tsao SW: Stable expression of EBERs in
immortalized nasopharyngeal epithelial cells confers resistance to
apoptotic stress. Mol Carcinog 2005, 44:92-101.
18. Arrand JR, Rymo L: Characterization of the major Epstein-Barr virusspecific
RNA in Burkitt lymphoma-derived cells. J Virol 1982, 41:376-389.
19. Rosa MD, Gottlieb E, Lerner MR, Steitz JA: Striking similarities are exhibited
by two small Epstein-Barr virus-encoded ribonucleic acids and the
adenovirus-associated ribonucleic acids VAI and VAII. Mol Cell Biol 1981,
1:785-796.
20. Howe JG, Shu MD: Epstein-Barr virus small RNA (EBER) genes: unique
transcription units that combine RNA polymerase II and III promoter
elements. Cell 1989, 57:825-834.
21. Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Bauml G, Rucker O,
Schwarzmann F, Wolf H, Minarovits J: The in vivo binding site for
oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding
RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis. Med
Sci Monit 2003, 9:HY1-9.
22. Felton-Edkins ZA, White RJ: Multiple mechanisms contribute to the
activation of RNA polymerase III transcription in cells transformed by
papovaviruses. J Biol Chem 2002, 277:48182-48191.
23. Gottesfeld JM, Johnson DL, Nyborg JK: Transcriptional activation of RNA
polymerase III-dependent genes by the human T-cell leukemia virus
type 1 tax protein. Mol Cell Biol 1996, 16:1777-1785.
24. Hoeffler WK, Kovelman R, Roeder RG: Activation of transcription factor IIIC
by the adenovirus E1A protein. Cell 1988, 53:907-920.
25. Larminie CG, Sutcliffe JE, Tosh K, Winter AG, Felton-Edkins ZA, White RJ:
Activation of RNA polymerase III transcription in cells transformed by
simian virus 40. Mol Cell Biol 1999, 19:4927-4934.
26. Wang HD, Trivedi A, Johnson DL: Hepatitis B virus X protein induces RNA
polymerase III-dependent gene transcription and increases cellular
TATA-binding protein by activating the Ras signaling pathway. Mol Cell
Biol 1997, 17:6838-6846.
27. Greifenegger N, Jager M, Kunz-Schughart LA, Wolf H, Schwarzmann F:
Epstein-Barr virus small RNA (EBER) genes: differential regulation during
lytic viral replication. J Virol 1998, 72:9323-9328.
28. Rooney C, Howe JG, Speck SH, Miller G: Influence of Burkitt’s lymphoma
and primary B cells on latent gene expression by the nonimmortalizing
P3J-HR-1 strain of Epstein-Barr virus. J Virol 1989, 63:1531-1539.
29. Felton-Edkins ZA, Kondrashov A, Karali D, Fairley JA, Dawson CW, Arrand JR,
Young LS, White RJ: Epstein-Barr virus induces cellular transcription
factors to allow active expression of EBER genes by RNA polymerase III.
J Biol Chem 2006, 281:33871-33880.
30. Alfieri C, Birkenbach M, Kieff E: Early events in Epstein-Barr virus infection
of human B lymphocytes. Virology 1991, 181:595-608.
31. O’Neil JD, Owen TJ, Wood VH, Date KL, Valentine R, Chukwuma MB,
Arrand JR, Dawson CW, Young LS: Epstein-Barr virus-encoded EBNA1
modulates the AP-1 transcription factor pathway in nasopharyngeal
carcinoma cells and enhances angiogenesis in vitro. J Gen Virol 2008,
89:2833-2842.
32. Gahn TA, Sugden B: An EBNA-1-dependent enhancer acts from a
distance of 10 kilobase pairs to increase expression of the Epstein-Barr
virus LMP gene. J Virol 1995, 69:2633-2636.
33. Sample J, Henson EB, Sample C: The Epstein-Barr virus nuclear protein 1
promoter active in type I latency is autoregulated. J Virol 1992,
66:4654-4661.
34. Sugden B, Warren N: A promoter of Epstein-Barr virus that can function
during latent infection can be transactivated by EBNA-1, a viral protein
required for viral DNA replication during latent infection. J Virol 1989,
63:2644-2649.
35. Wood VH, O’Neil JD, Wei W, Stewart SE, Dawson CW, Young LS: Epstein-
Barr virus-encoded EBNA1 regulates cellular gene transcription and
modulates the STAT1 and TGFbeta signaling pathways. Oncogene 2007,
26:4135-4147.
36. Mrazek J, Kreutmayer SB, Grasser FA, Polacek N, Huttenhofer A: Subtractive
hybridization identifies novel differentially expressed ncRNA species in
EBV-infected human B cells. Nucleic Acids Res 2007, 35:e73.
37. Nandy C, Mrázek J, Stoiber H, Grässer FA, Hüttenhofer A, Polacek N:
Epstein-Barr virus-induced expression of a novel human vault RNA. J Mol
Biol 2009, 388:776-784.
38. Marshall L, Kenneth NS, White RJ: Elevated tRNA(iMet) synthesis can drive
cell proliferation and oncogenic transformation. Cell 2008, 133:78-89.
39. Chau CM, Lieberman PM: Dynamic chromatin boundaries delineate a
latency control region of Epstein-Barr virus. J Virol 2004, 78:12308-12319.
40. Ambinder RF, Shah WA, Rawlins DR, Hayward GS, Hayward SD: Definition
of the sequence requirements for binding of the EBNA-1 protein to its
palindromic target sites in Epstein-Barr virus DNA. J Virol 1990,
64:2369-2379.
41. Gomez-Roman N, Grandori C, Eisenman RN, White RJ: Direct activation of
RNA polymerase III transcription by c-Myc. Nature 2003, 421:290-294.
42. Chen W, Bocker W, Brosius J, Tiedge H: Expression of neural BC200 RNA in
human tumours. J Pathol 1997, 183:345-351.
43. Marshall L, White RJ: Non-coding RNA production by RNA polymerase III
is implicated in cancer. Nat Rev Cancer 2008, 8:911-914.
44. White RJ: RNA polymerases I and III, non-coding RNAs and cancer. Trends
Genet 2008, 24:622-629.
45. Johnson SA, Dubeau L, Johnson DL: Enhanced RNA polymerase IIIdependent
transcription is required for oncogenic transformation. J Biol
Chem 2008, 283:19184-19191.
46. Howe JG, Shu MD: Upstream basal promoter element important for
exclusive RNA polymerase III transcription of the EBER 2 gene. Mol Cell
Biol 1993, 13:2655-2665.
47. Wensing B, Stuhler A, Jenkins P, Hollyoake M, Karstegl CE, Farrell PJ: Variant
chromatin structure of the oriP region of Epstein-Barr virus and
regulation of EBER1 expression by upstream sequences and oriP. J Virol
2001, 75:6235-6241.
48. Adamson AL, Darr D, Holley-Guthrie E, Johnson RA, Mauser A, Swenson J,
Kenney S: Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1
activate the ATF2 transcription factor by increasing the levels of
phosphorylated p38 and c-Jun N-terminal kinases. J Virol 2000,
74:1224-1233.
49. Eliopoulos AG, Young LS: Activation of the cJun N-terminal kinase (JNK)
pathway by the Epstein-Barr virus-encoded latent membrane protein 1
(LMP1). Oncogene 1998, 16:1731-42.
50. Kieser A, Kilger E, Gires O, Ueffing M, Kolch W, Hammerschmidt W: Epstein-
Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun
N-terminal kinase cascade. EMBO J 1997, 16:6478-6485.
51. Roberts ML, Cooper NR: Activation of a ras-MAPK-dependent pathway by
Epstein-Barr virus latent membrane protein 1 is essential for cellular
transformation. Virology 1998, 240:93-99.
52. Canaan A, Haviv I, Urban AE, Schulz VP, Hartman S, Zhang Z, Palejev D,
Deisseroth AB, Lacy J, Snyder M, Gerstein M, Weissman SM: EBNA1
regulates cellular gene expression by binding cellular promoters. Proc
Natl Acad Sci USA 2009, 106(52):22421-6.
53. Dresang LR, Vereide DT, Sugden B: Identifying sites bound by Epstein-Barr
virus nuclear antigen 1 (EBNA1) in the human genome: defining a
position-weighted matrix to predict sites bound by EBNA1 in viral
genomes. J Virol 2009, 83:2930-2940.
54. Henderson A, Ripley S, Heller M, Kieff E: Chromosome site for Epstein-Barr
virus DNA in a Burkitt tumor cell line and in lymphocytes growthtransformed
in vitro. Proc Natl Acad Sci USA 1983, 80:1987-1991.
55. Arrand JR: Expressed but Enigmatic RNAs. Epstein-Barr Virus Report 2000,
7:145-149.
56. Marechal V, Dehee A, Chikhi-Brachet R, Piolot T, Coppey-Moisan M,
Nicolas JC: Mapping EBNA-1 domains involved in binding to metaphase
chromosomes. J Virol 1999, 73:4385-4392.
57. Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI: A modified
oestrogen receptor ligand-binding domain as an improved switch for
the regulation of heterologous proteins. Nucleic Acids Res 1995,
23:1686-1690.
58. Chen X, Arrand JR: Establishment of a cell line producing a recombinant
Epstein-Barr Virus expressing GFP. Chinese Journal of Microbiology and
Immunology 2003, 23:87-90.
59. Yao Y, Minter HA, Chen X, Reynolds GM, Bromley M, Arrand JR:
Heterogeneity of HLA and EBER expression in Epstein-Barr virusassociated
nasopharyngeal carcinoma. Int J Cancer 2000, 88:949-955.
60. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods
2001, 25:402-408.
61. Morris MA, Dawson CW, Wei W, O’Neil JD, Stewart SE, Jia J, Bell AI,
Young LS, Arrand JR: Epstein-Barr virus-encoded LMP1 induces a
hyperproliferative and inflammatory gene expression programme in
cultured keratinocytes. J Gen Virol 2008, 89:2806-2820.
62. Goodfellow SJ, Graham EL, Kantidakis T, Marshall L, Coppins BA, Oficjalska-
Pham D, Gerard M, Lefebvre O, White RJ: Regulation of RNA polymerase III
transcription by Maf1 in mammalian cells. J Mol Biol 2008, 378:481-491.